معلومات عضو التدريس

Dr. Nagham Nafiz Hendi is an Assistant Professor at the Faculty of Pharmacy, Applied Science Private University, Jordan, specializing in biomedical sciences, genomics, and clinical pharmacy. She earned her Ph.D. in Biomedical and Biological Sciences from Hamad Bin Khalifa University, Qatar (2023), graduating at the top of her class with distinction and receiving a fully funded doctoral scholarship. She also holds an M.Sc. in Clinical Pharmacy from the University of Jordan (2017) and a B.Sc. in Pharmacy (2015), both with first-class excellent academic standing.
Dr. Hendi?s research advances precision medicine by integrating genomics and translational biomedicine, pharmacogenomics, multi-omics, bioinformatics, and machine learning. Her work encompasses population genetic structure, genetic and molecular mechanisms of complex diseases, and the functional characterization of novel genes, particularly in underrepresented populations. Dr. Hendi previously held academic and postdoctoral appointments at Middle East University, Sidra Medicine, Hamad Bin Khalifa University, and the University of Jordan. She received the Paul Dudley White International Scholar Award (2024) from the American Heart Association. She contributes to peer-reviewed scientific publications, international conferences, funded research projects, postgraduate supervision, scientific peer review, and international scientific collaborations. She is a member of the American Society of Human Genetics and the European Society of Human Genetics.

- 2023 | Ph.D. in Biomedical and Biological Sciences: College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation, Doha, Qatar. Graduated with distinction, ranking first in her class. Doctoral dissertation: "Genome-Wide Association Study of Vitamin D Deficiency in the Middle East with a Relevant Characterization of the Novel SDR42E1 Gene."

- 2017 | M.Sc. in Clinical Pharmacy: School of Pharmacy, The University of Jordan, Amman, Jordan. Graduated with distinction, ranking first in her class. Master's thesis: "Patient Characteristics Associated with Chronic Hepatitis C-Induced Neutropenia."

- 2015 | B.Sc. in Pharmacy: Faculty of Pharmacy, Zarqa University, Jordan. Graduated with distinction, ranking first in her class.

- 2025-Present | Assistant Professor: Department of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Applied Science Private University, Jordan.

- 2024-2025 | Assistant Professor: Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Middle East University, Jordan.

- 2024-2025 | Postdoctoral Scientist: Department of Bioinformatics, Systems Biology and Immunology, Sidra Medicine, Qatar Foundation, Qatar.

- 2023-2024 | Postdoctoral Research Fellow: Genomics and Translational Biomedicine, Hamad Bin Khalifa University, Qatar.

- 2021-2023 | Research Assistant: Genomics and Translational Biomedicine, Hamad Bin Khalifa University, Qatar.

- 2020-2021 | Teaching Assistant: Genomics and Translational Biomedicine, Hamad Bin Khalifa University, Qatar.

- 2018-2019 | Lecturer: Faculty of Pharmacy, Al-Balqa Applied University, Jordan.

- 2017-2019 | Clinical Lecturer: School of Pharmacy, The University of Jordan, Jordan.

- 2015-2017 | Teaching and Research Assistant: School of Pharmacy, The University of Jordan, Jordan.

- 2015-2016 | Clinical Pharmacist: Jordan University Hospital, Jordan.

- 2014-2015 | Pharmacist: Orange Pharmacy and Al-Manhal Pharmacy, Jordan.

- 2023-Present | Scientific Peer Reviewer: Reviewing manuscripts for international scientific journals and publishers, including Scientific Reports, Frontiers, MDPI, and Elsevier.

Dr. Hendi?s research integrates population and functional genomics, pharmacogenomics, multi-omics, and translational biomedicine to investigate the genetic and molecular mechanisms of complex diseases and advance precision medicine. Her expertise encompasses genetic diversity and population structure, genome-wide association studies (GWAS), polygenic risk scores, and functional genomics using CRISPR/Cas9. She applies bioinformatics, integrative multi-omics (including transcriptomics and epigenomics), and artificial intelligence and machine learning to investigate gene function, identify disease biomarkers and therapeutic targets, and advance genetic risk prediction and personalized therapeutics, with particular emphasis on underrepresented populations.